Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

July 08, 2008; 71 (2) Resident and Fellow Section

Teaching NeuroImage: Cerebrotendinous xanthomatosis

Brijesh P. Mehta, Robert H. Shmerling
First published July 7, 2008, DOI: https://doi.org/10.1212/01.wnl.0000316806.01406.74
Brijesh P. Mehta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert H. Shmerling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Teaching NeuroImage: Cerebrotendinous xanthomatosis
Brijesh P. Mehta, Robert H. Shmerling
Neurology Jul 2008, 71 (2) e4; DOI: 10.1212/01.wnl.0000316806.01406.74

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1383

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

A 57-year-old man with cerebrotendinous xanthomatosis (CTX) was admitted to the hospital after a fall. He had been diagnosed with CTX in his 30s and had had numerous complex-partial seizures, which occur in 50% of adult patients.1 Seizures were characterized by staring spells and speech deficits, occasionally generalizing to tonic-clonic leg movements. He had marked enlargement of the tongue and Achilles tendons (figure, A–D). Neurologic examination was notable for dementia, spasticity, and ataxia. Brain MRI revealed lesions in the temporal lobes, globus pallidus, and dentate nucleus of the cerebellum (figure, E, F), thought to be from lipid accumulation and reactive astrocytosis.2 Additionally, hemosiderin deposits with calcification were present in the cerebellar hemispheres (figure, G, H). Biochemical testing revealed a high plasma cholestanol level (3.04 mg/dL, >10 times normal).The patient had been treated with chenodeoxycholic acid, but did not receive it for over a year because of short supply worldwide. Lack of recent therapy was associated with an increased frequency of seizures, prominent tongue protrusion, and further enlargement of the Achilles tendons.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure Patient with cerebrotendinous xanthomatosis

Physical examination demonstrated enlargement of the tongue (A) and Achilles tendons (B). Axial (C) and sagittal (D) T1-weighted MRI scans confirmed hypertrophy of the Achilles tendons. Brain MRI FLAIR sequences showed cortical and subcortical hyperintensities in the temporal lobes (arrows, E) and globus pallidus (arrowheads, E). T2-weighted MR images revealed cerebellar hyperintensities within the dentate nucleus (F). Hypointensities were seen on T1-weighted and susceptibility MRI scans within the cerebellum at the level of the midbrain (G, H).

Footnotes

  • Disclosure: The authors report no disclosures.

REFERENCES

  1. 1.↵
    Federico A, Dotti MT. Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 2003;18:633–638.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Barkhof F, Verrips A, Wesseling P, et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathological findings. Radiology 2000;217:869–876.
    OpenUrlPubMed
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease

Dr. Rizwan S. Akhtar and Dr. Sarah Brooker

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Cognitive Disorders/Dementia
  • MRI
  • Metabolic disease (inherited)
  • Lipidoses
  • Partial seizures

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Resident and Fellow Section
    Clinical Reasoning: A case of treatable spastic paraparesis
    Jonathan H. McKinnon, E. Peter Bosch et al.
    Neurology, August 06, 2012
  • Clinical/Scientific Notes
    THE FIRST CEREBROTENDINOUS XANTHOMATOSIS FAMILY FROM ARGENTINA: A NEW MUTATION IN CYP27A1 GENE
    M. Szlago, G. N. Gallus, A. Schenone et al.
    Neurology, January 28, 2008
  • Article
    Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start
    Bianca M.L. Stelten, Hidde H. Huidekoper, Bart P.C. van de Warrenburg et al.
    Neurology, December 07, 2018
  • Resident & Fellow Section
    Teaching NeuroImages: Spinal xanthomatosis
    A misdiagnosed, treatable cause of progressive myelopathy
    Cristina Valencia-Sanchez, Dean M. Wingerchuk, Radhika Dhamija et al.
    Neurology, July 07, 2020
Neurology: 100 (22)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise